B cells reappear less mature and more activated after their anti-CD20–mediated depletion in multiple sclerosis

B cell depletion via anti-CD20 antibodies is a highly effective treatment for multiple sclerosis (MS). However, little is known about the maturation/activation stage of the returning B cell population after treatment cessation and the wider effects on other immune cells. In the present study, 15 rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Nissimov, Nitzan, Hajiyeva, Zivar, Torke, Sebastian, Grondey, Katja, Brück, Wolfgang, Häusser-Kinzel, Silke, Weber, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2020
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568262/
https://www.ncbi.nlm.nih.gov/pubmed/32999069
http://dx.doi.org/10.1073/pnas.2012249117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568262/
https://www.ncbi.nlm.nih.gov/pubmed/32999069
http://dx.doi.org/10.1073/pnas.2012249117

Ejemplares similares